In Vitro Susceptibilities of Clinical Yeast Isolates to the New Antifungal Eberconazole Compared with Their Susceptibilities to Clotrimazole and Ketoconazole

The antifungal activity of eberconazole, a new imidazole derivative, against 124 clinical isolates of Candida comprising eight different species and to 34 isolates of Cryptococcus neoformans was compared to those of clotrimazole and ketoconazole. MICs of eberconazole, determined by the National Comm...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Torres-Rodríguez, Josep M., Mendez, Raúl, López-Jodra, Olga, Morera, Yolanda, Espasa, Mateu, Jimenez, Teresa, Lagunas, Carme
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society for Microbiology 1999
Ämnen:
Susceptibility
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC89253/
https://ncbi.nlm.nih.gov/pubmed/10223946
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk